UKSPA News

Mission Street and BGO Secure Planning Consent for the Largest Purpose-Built Commercial Science Scheme in Central Oxford

  • Specialist sciences developer Mission Street and BGO have secured resolution to grant planning consent for a purpose-built commercial science scheme totaling 180,000 sq ft
  • Consent coincides with practical completion of neighboring Inventa, a 65,000 sq ft state of-the-art lab, office and collaboration building
  • The two schemes are the first to be delivered in Oxford’s West End – which has a pipeline of over 2 million sq ft of commercial and University buildings

Mission Street, a specialist investor, developer and operator of science and innovation real estate, and BGO, a global real estate investment management advisor, have secured resolution to grant planning permission from Oxford City Council for Phase 2 of their development in the West End of Oxford.

Known as Fabrica, and part of Mission Street’s joint venture with BGO, the new-build scheme will provide 180,000 sq ft of prime innovation real estate within a 10 minute walk from Oxford station and city centre. Designed by global architecture firm NBBJ, Fabrica has been designed to provide full flexibility of wet labs and offices across 5 floors in what will be a next-generation commercial sciences building.

The planning success comes in the same week as Practical Completion of Mission Street/ BGO’s Inventa building which provides 65,000 sq ft of lab, office and collaboration space. The scheme provides large lateral floor plates separated by two “high-street” atriums serving providing 8,000 sq ft of collaboration and breakout space for occupiers

Inventa and Fabrica will provide the first commercial science schemes in the West End, Oxford’s central science district which is set to be transformed over the short and medium term in response to a shifting trend towards more sustainable, easily accessible urban science locations. Over 2 million sq ft of commercial and University science buildings have been identified within the West End pipeline with Nuffield College and Oxford City Council’s Oxpens scheme awaiting determination.

As part of a joint venture BGO and Mission Street are delivering over 1.5 million of lab and office space in key strategic UK locations, including the “ Golden Triangle” of Oxford, Cambridge and London.

CBRE and Bidwells are advising on the leasing.

Artem Korolev, CEO of Mission Street, said:

“The decision to grant planning permission for Fabrica is a significant statement for the city of Oxford and for the Mission Street-BGO joint venture. This is the largest commercial Sciences scheme to gain consent in central Oxford and recognises the growing trend towards urban Science. The benefits for future occupiers are clear – proximity to Oxford train station and the city centre provides access to wider talent pools, ability to adopt sustainable travel methods, access to the amenities and cultural offerings of the city centre as well as the key anchors including the University. We’re extremely excited to be at the forefront of this transformation of the West End.”

Colin Brown, Development Director of Mission Street, said:

“Having just signed off practical completion of Inventa, we’re really encouraged by this decision on Fabrica. The committee approval is the result of two years of hard work and extensive consultation with the local authority, the public and wider stakeholders. The team are all very really proud of the building design as well as the wider benefits that Fabrica will bring.  

“Not only are we delivering a best-in-class science building in a supply starved market, but we are also delivering Oxford’s first Living Wage building and setting new standards in sustainable development for Science buildings. I would like to thank our fantastic team as well as those within OCC and other stakeholders who have contributed to positively to the process.”

CGI credit: NBBJ

Member Related To This Article

Roz Bird appointed Interim Chair of UK Science Park Association

Learn More

New Learning Resource Available: FTIR Essentials Guide

Learn More

AberInnovation Reports Ahead-of-Plan Growth in Sixth Year, Passing Milestones of Impact and Leveraged Investment

Learn More

Three scaling companies across ecology, fusion energy and immersive technology join Milton Park

Learn More

Statement from Stevenage Bioscience Catalyst on GSK’s continued investment in UK life sciences

Learn More

Subscribe to Our Newsletter to Keep Up to Date With the Latest UKSPA News

UKSPA
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.